This post is from a suggested group
Welcome to the group! Let's Thrive together ❤️ we are here to assist you! Blessings ❤️- Christina

View groups and posts below.
This post is from a suggested group
Welcome to the group! Let's Thrive together ❤️ we are here to assist you! Blessings ❤️- Christina
This post is from a suggested group
This post is from a suggested group

Wishing peace for each of you this thanksgiving🫶🏾
This post is from a suggested group
Good morning everyone! Today I just saw that we had a few new members in the group so please be sure to welcome them🫶🏾🥳💕
Y’all have an amazing day and remember there’s nothing we can’t do we just have to be creative with how we do it! Fear cripples but courage strengthens! Get up and do the thing that you’ve been putting of but take it I e step at a time. You got this💪🏽👏🏾
This post is from a suggested group
This post is from a suggested group
Hey everyone! I just wanted to check in and see how everyone has been doing? Share something positive that happened to you this week. I can’t wait to here your stories of
Resilience💪🏽
Coach Lashonda
I started a personal 21 Day Prayer challenge that includes fasting. I’m on day 4 today. I wake up not moving from my position in bed. I say Thank You Jesus several times as my consciousness is waking up. I immediately go into prayer in bed then on into worship service while I get ready for work. Then in my office I pray again and start journaling my day, my Thankfulness, my gratefulness. And I start my day.
This post is from a suggested group
The Ticagrelor Market continues to grow as incidences of cardiovascular disease, coronary artery disease, and ischemic stroke rise globally.
Ticagrelor, a potent oral antiplatelet agent, is widely used to prevent thrombotic cardiovascular events, particularly in patients undergoing angioplasty or experiencing acute coronary syndromes. It offers faster platelet inhibition and superior protection compared to traditional agents in select patient groups, making it a preferred therapy in many clinical protocols. Expanded cardiology infrastructure, rising awareness about secondary-prevention therapies, and guideline-recommended adoption of advanced antiplatelet drugs support market growth. Increased hospital admissions for heart attacks, rapid expansion of cardiac emergency centers, and higher percutaneous coronary intervention volumes further elevate demand.
Research continues exploring ticagrelor’s therapeutic potential in stroke prevention, peripheral artery disease, post-surgery thrombotic complications, and inflammatory cardiovascular conditions. Manufacturers focus on improving patient affordability through generic launches, while ongoing pharmacogenomic studies enhance personalized prescribing. Bleeding-risk management, drug-interaction considerations, and patient-adherence challenges remain…
This post is from a suggested group
This post is from a suggested group
We welcome you all! We will connect with our zoom in the new year ! Any suggestions- please feel free to list them here. Sending hugs your way